Login

Vection Technologies Ltd's software adapts existing CAD programs for real-time collaboration and visualization. 00:10:00

Share On Facebook Share On Twitter

Gianmarco Biagi is the CEO of Vection Technologies

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
David Solomon: Journey of Fulfillment and Success - Insights from the CEO of Goldman Sachs | Stanford GSB
00:10:00
Candente Copper CEO Joanne Freeze Discusses Yariako Norte Project PEA Highlights
00:10:00
Future of Custody: How Fireblocks is Redefining Security for Digital Assets|Zack Rosen,Investor,Ribbit Capital
00:10:00
CEO's Reflection on Sustainable Growth and Integration in Real Estate Development |Panote Sirivadhanabhakdi, Group CEO , Frasers Property.
00:10:00
Empowering Digital Success: Tools and Insights for Wealth Management Strategies by Lee Francis at CREALOGIX | Oliver Weber, Chief Executive Officer of Crealogix Holding AG
00:10:00
Examining the Dynamic Evolution of Credit Markets: Insights from Mark Okada | Mark Okada, CIO,  Highland Capital Management .
00:00:00
Ulrich von Andrian Mallinckrodt Professor of Immunopathology at Harvard Medical School| Understanding Immune Cell Migration
00:10:00
Ho Kuen Loon, Group CEO, and Ng Chong Jin, Group General Counsel of Fullerton Health, discuss their award-winning project and outline future plans for the company.
00:10:00
Sebastien Paré is the Chief Executive Officer of VIQ Solutions Inc.
00:10:00
Investors should 'stay the course' amid market uncertainty|Tim Buckley,CEO,Vanguard
00:10:00
Interview with Altech Chemicals at One-to-One Mining Conference
00:10:00
Strategic Diamond Supply: Near-Term Production and Quality Focus

© 2017 - Neuhu+